Does Perinatal Phenobarbital Exposure Affect Developmental Outcome at Age 2?

The Objective of this paper is to determine if phenobarbital exposure during pregnancy affects developmental outcome at age 2 years. Between 1991 and 1994, 401 pregnant patients at risk for delivery prior to 34 weeks' gestation were invited to participat; 48 mothers declined entry. Before delivery, pharmacy randomized the pregnant women to receive phenobarbital and vitamin K or identically appearing placebo in a blinded fashion. Developmental follow-up at age 2 years was performed. Children from the treatment group scored signifcantly lower on the Bayler Mental Developmental Index (mean MDI ± 1 SD) than children whose mothers were randomized to the placebo group [104 ± 21 ( N = 59) vs. 113 ± 22 ( N = 62), P = 0.023]. Of 36 independent variables, randomization group was one of five that individually contributed to the prediction of the Bayley MDI score ( P < 0.05). It was concluded that perinatal phenobarbital therapy may impair developmental outcome..

Medienart:

E-Artikel

Erscheinungsjahr:

1999

Erschienen:

Stuttgart: Georg Thieme Verlag ; 1999

Reproduktion:

Thieme Zeitschriftenarchive 1980-2007

Enthalten in:

Zur Gesamtaufnahme - volume:16

Enthalten in:

American journal of perinatology - 16(1999), 02 vom: März, Seite 51-60

Sprache:

Englisch

Beteiligte Personen:

Thorp, James A. [VerfasserIn]
O'Connor, Mary [VerfasserIn]
Jones, Angela M.H. [VerfasserIn]
Hoffman, Edward L. [Sonstige Person]
Belden, Brian [Sonstige Person]

Links:

dx.doi.org [Deutschlandweit zugänglich]

Themen:

Antenatal exposure
Developmental outcome
Intelligence
Perinatal exposure
Phenobarbital

Umfang:

10

doi:

10.1055/s-2007-993836

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLEJ227391578